1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

Cocktails for plasma cell studies: Clonalpath™ and Clonalpath™–Plus

Clonalpath™ and Clonalpath™-Plus have been designed for an optimal differentiation between monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) based on the percentage of immunophenotypically normal plasma cells. Pathological plasma cells can be differentiated from normal plasma cells according to their immunophenotypic pattern of expression of anti-CD19, CD56, CD45 and CD38.

 

Clonalpath™ contains the following antibody combination for the identification and characterization of plasma cells in a single vial:

 

FITC
PE
PE-Cyanine5
CD38
CD56
CD19

Clonalpath™-Plus includes anti-CD45 antibody that is very useful for characterization of normal and pathological plasma cells:

 

FITC
PE
PE-Cyanine5
APC
CD38
CD56
CD19
CD45

 

Clonalpath
Abnormal bone marrow sample stained with Clonalpath™ - Plus cocktail

 

Description
Size
Catalog code
Status
TDS
Clonalpath™
100 tests
CYT-CP-100
RUO
PDF
Clonalpath™-Plus
50 tests
CYT-CP45
RUO
PDF

 

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.

I accept cookies from this site.

EU Cookie Directive Module Information